58 results
Page 2 of 3
6-K
EX-10.1
8tuig91o piqk
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
gq5ms
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.1
ft6keq1a51fr 7rd
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K/A
EX-99.2
3qqxaaaaneojz
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
g3sve
16 Sep 20
Enlivex Announces Allowance of New Chinese Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
ivwddi35jsx6nu
25 Aug 20
Enlivex Announces Allowance of New U.S. Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.2
1rtusqpevwwdy4
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
l5cns0v5kavw10b8
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
p1jtn84gx03u5iem46
18 Jun 20
Enlivex Announces Allowance of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
8:32am
6-K
EX-99.1
19iztw3hto31 i3u8v
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
yhrgu1l5y
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
olhea njlne409mc
18 May 20
Condensed Consolidated Financial Statements
4:30pm
424B5
y2ohp
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
hrzsqhz q9k6rc
26 Feb 20
Prospectus supplement for primary offering
8:23am
6-K
EX-99.1
b3925 8pa0dt7hblg1ot
24 Feb 20
Report of Foreign Private Issuer
6:30am
424B5
gxmndfaom03vb7z vvyd
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.1
3i41mo7tvr g0bll5
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
uzbyc3 clol5
14 Nov 19
Condensed Consolidated Financial Statements
7:30am